T-cell lymphoma patient harboring BCL11B mutations had favorable overall survival.

Cunte ChenLing HuangSichu LiuXinmiao JiangFeili ChenXiaojuan WeiHanguo GuoXiangbo ZengChengwu ZengGrzegorz K PrzybylskiWenyu LiYangqiu Li

Published in: Asia-Pacific journal of clinical oncology (2023)

BCL11B mutations were associated with favorable clinical outcome for TCL patients; it might be considered as a novel biomarker for TCL prognostic stratification.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
case report
patient reported outcomes